Biomea Fusion, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Biomea Fusion, Inc. (BMEA) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-03-24
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2024-12-31 was -$61.00K.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $7.00K.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $2.54M.
- Biomea Fusion, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2020 was $38.00K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | -$61.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | -$61.00K derived: sum of 3 quarters · filed 2026-03-24 | -$28.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-05 | -$61.00K derived: sum of 2 quarters · filed 2026-03-24 | -$28.00K derived: sum of 3 quarters · filed 2026-03-24 | -$27.00K derived: sum of 4 quarters · filed 2026-03-24 |
| 2024-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$28.00K derived: sum of 2 quarters · filed 2026-03-24 | -$27.00K derived: sum of 3 quarters · filed 2026-03-24 | $7.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $34.00K derived: sum of 2 quarters · filed 2025-11-04 | $68.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $35.00K 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-05 | |||
| 2023-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$371.00K derived: sum of 2 quarters · filed 2024-10-29 | $4.00K 10-Q · filed 2024-10-29 | $2.27M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $28.00K 10-Q · filed 2024-07-31 | $2.29M derived: sum of 3 quarters · filed 2025-03-31 | |
| 2023-03-31 | $375.00K 10-Q · filed 2024-05-02 | $2.64M derived: sum of 2 quarters · filed 2025-03-31 | ||
| 2022-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.54M 10-K · filed 2025-03-31 | ||
| 2022-09-30 | $276.00K 10-Q · filed 2023-10-30 | |||
| 2021-09-30 | -$507.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $74.00K derived: sum of 2 quarters · filed 2022-11-07 | $103.00K 10-Q · filed 2022-11-07 | $129.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $581.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $610.00K 10-Q · filed 2022-08-01 | $636.00K derived: sum of 3 quarters · filed 2023-03-28 | |
| 2021-03-31 | $29.00K 10-Q · filed 2022-05-16 | $55.00K derived: sum of 2 quarters · filed 2023-03-28 | ||
| 2020-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $38.00K 10-K · filed 2023-03-28 | ||
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |